ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $679,000 | -20.1% | 48,205 | +37.3% | 0.00% | 0.0% |
| Q1 2022 | $850,000 | +3.7% | 35,100 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $820,000 | -70.4% | 35,100 | -67.3% | 0.00% | -66.7% |
| Q1 2021 | $2,766,000 | -78.9% | 107,185 | -56.4% | 0.00% | -76.9% |
| Q4 2020 | $13,129,000 | -18.3% | 245,573 | -36.9% | 0.01% | -31.6% |
| Q3 2020 | $16,062,000 | -20.3% | 389,377 | -6.3% | 0.02% | -17.4% |
| Q2 2020 | $20,146,000 | +71.1% | 415,622 | +49.1% | 0.02% | +43.8% |
| Q1 2020 | $11,776,000 | +25.1% | 278,727 | +26.7% | 0.02% | +77.8% |
| Q4 2019 | $9,410,000 | +357.5% | 219,967 | +287.1% | 0.01% | +350.0% |
| Q3 2019 | $2,057,000 | +35.4% | 56,829 | -0.0% | 0.00% | +100.0% |
| Q2 2019 | $1,519,000 | -7.5% | 56,833 | -7.1% | 0.00% | -50.0% |
| Q1 2019 | $1,643,000 | +88.9% | 61,194 | +12.8% | 0.00% | +100.0% |
| Q4 2018 | $870,000 | +38.8% | 54,267 | +94.5% | 0.00% | 0.0% |
| Q1 2018 | $627,000 | -25.4% | 27,905 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $840,000 | -23.3% | 27,905 | -4.0% | 0.00% | 0.0% |
| Q3 2017 | $1,095,000 | +31.1% | 29,053 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $835,000 | -62.7% | 29,138 | -55.4% | 0.00% | -50.0% |
| Q1 2017 | $2,239,000 | +29.4% | 65,333 | +8.9% | 0.00% | 0.0% |
| Q4 2016 | $1,730,000 | -19.8% | 59,988 | -9.4% | 0.00% | 0.0% |
| Q3 2016 | $2,158,000 | -49.6% | 66,192 | -49.8% | 0.00% | -60.0% |
| Q2 2016 | $4,283,000 | +89.7% | 131,946 | +63.4% | 0.01% | +66.7% |
| Q1 2016 | $2,258,000 | -16.8% | 80,750 | +6.5% | 0.00% | 0.0% |
| Q4 2015 | $2,714,000 | +8.3% | 75,800 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $2,507,000 | -21.0% | 75,800 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $3,174,000 | – | 75,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |